Mark Carpenter Selected Research

Neoplasms (Cancer)

1/2009	Genistein mechanisms and timing of prostate cancer chemoprevention in lobund-wistar rats.
5/2006	Resveratrol, but not EGCG, in the diet suppresses DMBA-induced mammary cancer in rats.
12/2005	Phase I study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: expression analysis of genes related to outcome.
11/2005	Intraperitoneal pretarget radioimmunotherapy with CC49 fusion protein.
10/2005	Intraperitoneal radioimmunotherapy with a humanized anti-TAG-72 (CC49) antibody with a deleted CH2 region.
11/2004	Site-specifically traced drug release and biodistribution of a paclitaxel-antibody conjugate toward improvement of the linker structure.
4/2004	Rapid identification of dihydropyrimidine dehydrogenase deficiency by using a novel 2-13C-uracil breath test.
4/2004	Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas.
9/2003	Antitumor efficacy of TRA-8 anti-DR5 monoclonal antibody alone or in combination with chemotherapy and/or radiation therapy in a human breast cancer model.
3/2003	Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark Carpenter Research Topics

Disease

12	Neoplasms (Cancer) 01/2009 - 08/2002
3	Breast Neoplasms (Breast Cancer) 06/2009 - 09/2003
2	Carcinoma (Carcinomatosis) 01/2009 - 08/2002
2	Carcinogenesis 05/2006 - 09/2005
2	Pancreatic Neoplasms (Pancreatic Cancer) 12/2005 - 11/2002
1	Pleural Empyema (Pyothorax) 03/2010
1	Prostatic Neoplasms (Prostate Cancer) 01/2009
1	Fetal Alcohol Spectrum Disorders 06/2007
1	Body Weight (Weight, Body) 05/2006
1	Diarrhea 12/2005
1	Flushing 09/2005
1	Blister (Bulla) 09/2005
1	Colorectal Neoplasms (Colorectal Cancer) 01/2004
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2003
1	Nausea 12/2002
1	Acidosis 12/2002
1	Vomiting 12/2002
1	Hypoxia (Hypoxemia) 08/2002
1	Infections 08/2002
1	Lung Neoplasms (Lung Cancer) 08/2002

Drug/Important Bio-Agent (IBA)

4	Monoclonal AntibodiesIBA 10/2005 - 03/2003
3	Cetuximab (Erbitux)FDA Link 11/2004 - 11/2002
2	PolyphenolsIBA 06/2009 - 05/2006
2	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 12/2005 - 04/2004
2	Pharmaceutical PreparationsIBA 11/2004 - 03/2003
2	Paclitaxel (Taxol)FDA LinkGeneric 09/2003 - 03/2003
2	ErbB Receptors (EGF Receptor)IBA 03/2003 - 11/2002
1	Heparin (Liquaemin)FDA LinkGeneric 03/2010
1	bisphenol AIBA 06/2009
1	Endocrine DisruptorsIBA 06/2009
1	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 01/2009
1	GenisteinIBA 01/2009
1	Phytoestrogens (Phytoestrogen)IBA 01/2009
1	aniracetamIBA 06/2007
1	Drinking WaterIBA 05/2006
1	ResveratrolIBA 05/2006
1	anthraceneIBA 05/2006
1	Capecitabine (Xeloda)FDA Link 12/2005
1	Messenger RNA (mRNA)IBA 12/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2005
1	Thymidine PhosphorylaseIBA 12/2005
1	Single-Chain AntibodiesIBA 11/2005
1	StreptavidinIBA 11/2005
1	Glycoproteins (Glycoprotein)IBA 11/2005
1	Proteins (Proteins, Gene)FDA Link 11/2005
1	AntibodiesIBA 10/2005
1	tumor-associated antigen 72IBA 10/2005
1	TECAIBA 09/2005
1	Biological ProductsIBA 09/2005
1	hydroxide ionIBA 11/2004
1	Fluorouracil (Carac)FDA LinkGeneric 04/2004
1	EmulsionsIBA 01/2004
1	Epithelial Cell Adhesion MoleculeIBA 01/2004
1	VaccinesIBA 01/2004
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2004
1	monophosphoryl lipid AIBA 01/2004
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2003
1	tigatuzumabIBA 09/2003
1	AntigensIBA 03/2003
1	Peptides (Polypeptides)IBA 03/2003
1	Bombesin Receptors (Bombesin Receptor)IBA 03/2003
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2003
1	Taxoids (Taxanes)IBA 03/2003
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 12/2002
1	Ephedrine FDA LinkGeneric 12/2002
1	Tyrosine (L-Tyrosine)FDA Link 11/2002
1	Epidermal Growth Factor (EGF)IBA 11/2002
1	Gemcitabine FDA Link 11/2002
1	CaspasesIBA 08/2002
1	enhanced green fluorescent proteinIBA 08/2002
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2002
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 08/2002

Therapy/Procedure

2	Therapeutics 05/2006 - 12/2002
2	Radiotherapy 12/2005 - 09/2003
2	Drug Therapy (Chemotherapy) 04/2004 - 09/2003
1	Chemoprevention 01/2009
1	Osteotomy 09/2005
1	Operative Surgical Procedures 04/2004
1	Injections 01/2004
1	Spinal Anesthesia 12/2002